Company Filing History:
Years Active: 2000-2008
Title: Innovations of Katarin Kalman
Introduction
Katarin Kalman is a prominent inventor based in Irvine, California. She has made significant contributions to the field of neuroscience and therapeutic development. With a total of 3 patents, her work focuses on the hKCa3/KCNN3 small conductance calcium activated potassium channel, which has implications for various neuropsychiatric disorders.
Latest Patents
Her latest patents include groundbreaking research on the hKCa3/KCNN3 gene. This gene is expressed in neuronal cells, skeletal muscle, heart, and lymphocytes. Alterations in the hKCa3/KCNN3 gene or its protein product may enhance susceptibility to schizophrenia and/or bipolar disorder. The invention provides methods for diagnosing and treating disorders associated with hKCa3/KCNN3. It also includes formulations for administering hKCa3/KCNN3 to patients and kits for detecting the presence of hKCa3/KCNN3 polypeptide or polynucleotide in samples.
Career Highlights
Katarin Kalman is affiliated with the University of California, where she conducts her research. Her work has garnered attention for its potential to impact the understanding and treatment of neuropsychiatric, neurological, neuromuscular, and immunological disorders.
Collaborations
Some of her notable coworkers include K George Chandy and J Jay Gargus. Their collaborative efforts have contributed to advancing research in their respective fields.
Conclusion
Katarin Kalman is a distinguished inventor whose work on the hKCa3/KCNN3 gene has the potential to revolutionize the diagnosis and treatment of various disorders. Her contributions to science and medicine continue to pave the way for future innovations.